Share tips thread (Vol 2)
Discussion
supercommuter said:
Greshamst said:
One hell of a 19% rise for Boohoo today.
There were quite a few holders on here, did people manage to sit out the past few months?
Sat it out, now back to my original holding value haha There were quite a few holders on here, did people manage to sit out the past few months?
Better than a loss i guess! I am annoyed a bit as I was looking at it yesterday thinking i might top up and average down my sp, but did not bother.
Question now is: continue to ride it out, or crystallise my losses at half of what they’ve been for the last few months...
Doh! Was meant to top up my BOO.L as it felt just too cheap at ~150p but been too busy with work!
Hopefully that'll scare the daytraders and shorters off and it'll start an upward trend again.
MTFB.L still languishing a bit and I think SXX.L still a good long term punt at these prices, even after the recent rise (only back to where it was 12 months ago).
So, may top up there...
Hopefully that'll scare the daytraders and shorters off and it'll start an upward trend again.
MTFB.L still languishing a bit and I think SXX.L still a good long term punt at these prices, even after the recent rise (only back to where it was 12 months ago).
So, may top up there...
dom9 said:
Doh! Was meant to top up my BOO.L as it felt just too cheap at ~150p but been too busy with work!
Hopefully that'll scare the daytraders and shorters off and it'll start an upward trend again.
MTFB.L still languishing a bit and I think SXX.L still a good long term punt at these prices, even after the recent rise (only back to where it was 12 months ago).
So, may top up there...
Just logged on here having not checked my holding today to have a pleasant surprise on Boo Hopefully that'll scare the daytraders and shorters off and it'll start an upward trend again.
MTFB.L still languishing a bit and I think SXX.L still a good long term punt at these prices, even after the recent rise (only back to where it was 12 months ago).
So, may top up there...
I hold both the other 2 as well (albeit it only small amounts), hoping they will both perform long term especially given all the positivity around the potential SXX have.
emicen said:
supercommuter said:
Greshamst said:
One hell of a 19% rise for Boohoo today.
There were quite a few holders on here, did people manage to sit out the past few months?
Sat it out, now back to my original holding value haha There were quite a few holders on here, did people manage to sit out the past few months?
Better than a loss i guess! I am annoyed a bit as I was looking at it yesterday thinking i might top up and average down my sp, but did not bother.
Question now is: continue to ride it out, or crystallise my losses at half of what they’ve been for the last few months...
alistair1234 said:
Anyone in IMM or know what is going on? Huge drop last week, started to recover a bit again.
I'm not but had a quick look:Published 17th April 4 days after the huge downturn:
(ShareCast News) - A recent Phase III study undertaken by drug discovery and development company ImmuPharma demonstrated a superior response rate from its lupus compound, Lupuzor, but, due to a high response rate in the placebo group, the group's superior response was unable to allow statistical significance to be reached and the trial's primary endpoint was not met.
Lupuzor demonstrated a superior response rate over the placebo of 52.5% to 44.6% in the primary analysis of the full analysis set of all 202 patients taking part in the study and also confirmed the "outstanding safety profile of Lupuzor", with zero serious adverse events reported.
Separately, following requests from both investigators and patients involved in the Phase III study, ImmuPharma launched an additional study permitting all patients who participated in the trial, to receive Lupuzor for the next six months in an open-label scheme with results to be gathered as an "extension" open-label study, independent of the Phase III trial.
ImmuPharma chairman Tim McCarthy, said, "Lupuzor has demonstrated, in this study, a superior response rate over placebo and its exceptional safety, giving it, we believe, a compelling product profile."
"Whilst we are disappointed at the high response in the placebo plus standard of care group that resulted in statistical significance not being reached between the two treatment groups, we believe Lupuzor has the potential to bring a much needed safe treatment to the millions of Lupus sufferers around the world," he added.
speedyguy said:
Same here I was in at 60p sold on profit, in at 55 sold at profit then in again at just over 40 and sold at profit.
Hindsight at keeping the 40's and selling at the £1 before getting on at the 70s is a wonderful thing.
No point worrying though, still made all in just not as much.
Just have to say it doesn't matter. Impossible to time it right, and it's just mostly down to luck if you do. It's the long term gain that matters. If you try and time it perfectly you're more likely to get burnt doing so.Hindsight at keeping the 40's and selling at the £1 before getting on at the 70s is a wonderful thing.
No point worrying though, still made all in just not as much.
NRS said:
speedyguy said:
Same here I was in at 60p sold on profit, in at 55 sold at profit then in again at just over 40 and sold at profit.
Hindsight at keeping the 40's and selling at the £1 before getting on at the 70s is a wonderful thing.
No point worrying though, still made all in just not as much.
Just have to say it doesn't matter. Impossible to time it right, and it's just mostly down to luck if you do. It's the long term gain that matters. If you try and time it perfectly you're more likely to get burnt doing so.Hindsight at keeping the 40's and selling at the £1 before getting on at the 70s is a wonderful thing.
No point worrying though, still made all in just not as much.
Obviously nothing was certain but buying PMO when it was in the 40s was hardly a blinding insight, question was really how did it ever get that low.
alistair1234 said:
Anyone in IMM or know what is going on? Huge drop last week, started to recover a bit again.
I was in this, kicking myself for not de-risking ahead of results but I got too greedy.As mentioned above the drug didn't deliver on its P3 trial, seemingly through a high response rate on the control group meaning clear efficacy wasn't established. They have some cash, but I don't think enough to redo the trial although potentially a deeper examination of the results could open up the possibility of using it for more targeted groups of patients. I can't see any short term recovery unless they can pull a rabbit out of a hat somehow.
There has been some horrendous ramping going on - I'd have gone short at 40p+ if I had an account at IG or similar.
alistair1234 said:
Anyone in IMM or know what is going on? Huge drop last week, started to recover a bit again.
Last RNS wasn't exactly the best. News like that was always going to have a pretty bad impact, and no doubt the herd effect of sellers helped push it down further. It's hard to see it going anywhere in the short term now, 5% down today.In the same industry, same MCAP, what are peoples opinions on Scancell (SCLP) ?
I've always had a soft spot for this one, but currently sat on the sidelines after making some good money back when it made the Moditope discovery. SP has just reached the placing price announced last week which was oversubscribed. Before this it was climbing nicely, and news-flow had improved in recent months.
Unable to get any real opinion on the products in trial. LSE forum has a resident lunatic ramper who would argue black is white and completely ruins any chance of getting any solid info. ADVFN the same. Why is it these companies attract such knobs?
In a nutshell the product appears to work, has hugely prolonged the life of the patients on the trial who otherwise probably wouldn't be with us now, and it's programmable to target different cancers. Only gripe is the trial size was too small and perhaps biased. That said, a new trial now has funding and if it comes good the market is almost limitless.
Anyone ever looked at it in more detail and come to any conclusions?
supercommuter said:
Zippee said:
supercommuter said:
bmwmike said:
Nice to see BOO up a bit today
Again today as well 
Still looking at Debenhams dividend but not sure how they can afford to pay that and whether they'll be around long term.
ReaperCushions said:
Glad I'm not alone in thinking that. The bad press has brought about the dip, but nothing has fundamentally changed. The only thing that might have come from the scandal is a large drop in users... which didn't happen. I felt like the drop in users is priced in.. but as it didn't happen... the price must head back to where it was (and beyond) very soon.
The same with Trump / Amazon as well, 24 hours of bad press and the Twitter warrior bashing them drops the price, but the business hasn't changed.
Well, it rocketed and is probably going to be a hold. I was on a CFD at x10 leverage, so 90% profit on that one.The same with Trump / Amazon as well, 24 hours of bad press and the Twitter warrior bashing them drops the price, but the business hasn't changed.
Amazon up 6.4%, so 64% profit - if it keeps up tomorrow..... it has a chance of plummeting, does that quite often after earnings, no matter how good the ER.
guindilias said:
Well, it rocketed and is probably going to be a hold. I was on a CFD at x10 leverage, so 90% profit on that one.
Bravo! Wish I had had the balls! Do all brokers offer such things? I use HL and don't see such an option, can't even figure out how to take a short position!Gassing Station | Finance | Top of Page | What's New | My Stuff